Status:
ACTIVE_NOT_RECRUITING
Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba
Lead Sponsor:
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Conditions:
Pityriasis Alba
Eligibility:
All Genders
5-14 years
Brief Summary
Pityriasis alba (PA) is a common, benign skin disorder occurring predominantly in children and adolescents. It is characterized by ill-defined hypopigmented macules and patches, round or oval in shape...
Detailed Description
The prospective cohort study will be conducted on the basis of Research Institute of Epidemiology, Microbiology and Infectious Disease, Ministry of Public Health of the Republic of Uzbekistan. Both i...
Eligibility Criteria
Inclusion
- Patients with Pityriasis alba
- Healthy individuals (control group)
Exclusion
- chronic and acute infectious diseases;
- endocrine diseases;
- congenital diseases;
- allergic dermatitis;
- bronchial asthma;
- allergic rhinitis and/or conjunctivitis;
- other skin disorders;
- history of using vitamin D supplements within three months ago, or use of any medication influencing endocrine parameters.
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT03443765
Start Date
May 1 2017
End Date
December 31 2025
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research institute of epidemiology, microbiology and infectious diseases
Tashkent, Uchtepa, Uzbekistan, 100133